Scarica l'app Stockscreener
5.10
5.00%
-0.30
Precedente Chiudi:
$5.40
Aprire:
$5.25
Volume 24 ore:
31,763
Relative Volume:
0.19
Capitalizzazione di mercato:
$38.06M
Reddito:
$16.03M
Utile/perdita netta:
$-18.83M
Rapporto P/E:
-1.4571
EPS:
-3.5
Flusso di cassa netto:
$-14.87M
1 W Prestazione:
+6.43%
1M Prestazione:
-14.78%
6M Prestazione:
-49.16%
1 anno Prestazione:
-26.71%
Intervallo 1D:
$5.1019
$5.3816
Intervallo di 1 settimana:
$4.465
$5.87
Portata 52W:
$4.465
$19.49
Electrocore Inc Stock (ECOR) Company Profile
Nome
Electrocore Inc
Settore
Industria
Telefono
973-290-0097
Indirizzo
200 FORGE WAY, ROCKAWAY
Confronta ECOR con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ECOR
Electrocore Inc
|
5.13 | 35.77M | 16.03M | -18.83M | -14.87M | -3.50 |
|
ABT
Abbott Laboratories
|
135.29 | 229.64B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
106.22 | 152.19B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
391.88 | 148.31B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
86.10 | 110.06B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
78.06 | 43.88B | 5.54B | 4.18B | 623.10M | 7.00 |
Electrocore Inc Stock (ECOR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2020-08-14 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2019-11-14 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| 2019-09-26 | Ripresa | Cantor Fitzgerald | Neutral |
| 2019-05-30 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2019-05-15 | Downgrade | BTIG Research | Buy → Neutral |
| 2019-05-09 | Iniziato | Noble Capital Markets | Outperform |
| 2018-09-21 | Iniziato | Cantor Fitzgerald | Overweight |
Mostra tutto
Electrocore Inc Borsa (ECOR) Ultime notizie
When Will electroCore, Inc. (NASDAQ:ECOR) Become Profitable? - simplywall.st
Insider Buying: Thomas Errico Acquires 10,000 Shares of electroC - GuruFocus
(ECOR) Trading Report - news.stocktradersdaily.com
INVESTOR ALERTelectroCore, Inc. (ECOR)Bronstein, Gewirtz & Grossman, LLC Reminds of Class Action and Lead Plaintiff Deadline: November 25, 2019 - ACCESS Newswire
ElectroCore anticipates $30M 2025 revenue amid product line expansion - MSN
electroCore Inc (ECOR) Q1 2025 Earnings Call Highlights: Revenue Surge and Strategic Acquisitions Drive Growth - GuruFocus
electroCore Inc (ECOR) Q1 2025 Earnings Call Highlights: Revenue Surge and Strategic ... - Yahoo Finance
Vagus Nerve Stimulators Market Is Booming Worldwide | LivaNova - openPR.com
Bioelectric Medicine Market Rises with Innovation in Neuromodulation Therapies | ElectroCore, Medtronic, Abbott - openPR.com
electroCore, Inc. (NASDAQ:ECOR) Q1 2025 Earnings Call Transcript - Insider Monkey
ElectroCore Reports Strong Q1 Growth and Strategic Expansion - TipRanks
Earnings call transcript: ElectroCore’s Q1 2025 revenue climbs 23%, stock dips - Investing.com
ElectroCore, Inc. (ECOR) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Finance
electroCore Inc Reports Q1 2025 Earnings: EPS Matches Estimates at -$0.47, Revenue Slightly Misses at $6.7 Million - GuruFocus
electroCore Announces First Quarter 2025 Financial Results - GlobeNewswire
electroCore, Inc. (ECOR): A Bull Case Theory - Insider Monkey
electroCore completes acquisition of neurotechnology solution provider NeuroMetrix - Yahoo
electroCore Acquires NeuroMetrix, Expands Pain Management Portfolio By Investing.com - Investing.com Nigeria
NeuroMetrix finalizes acquisition by electroCore - Investing.com Nigeria
NeuroMetrix finalizes acquisition by electroCore By Investing.com - Investing.com South Africa
ElectroCore Completes Merger With NeuroMetrix - marketscreener.com
ElectroCore completes acquisition of NeuroMetrix - MassDevice
electroCore Completes Acquisition of NeuroMetrix - Medical Product Outsourcing
Electrocore Completes Acquisition Of Neurometrix - marketscreener.com
Electrocore Completes Merger with NeuroMetrix - TipRanks
electroCore Acquires NeuroMetrix, Expands Pain Management Portfolio - Investing.com Australia
ECOR Completes Merger with NeuroMetrix to Bolster Health Solutio - GuruFocus
electroCore Completes Acquisition of NeuroMetrix, Gaining Access - GuruFocus
electroCore Completes Acquisition of NeuroMetrix, Gaining Access to its Quell Platform, Creating Significant Player in Non-Invasive Bioelectronic Technologies | ECOR Stock News - GuruFocus
electroCore Completes Acquisition of NeuroMetrix, Gaining Access to its Quell Platform, ... - Bluefield Daily Telegraph
electroCore Completes Acquisition of NeuroMetrix, Gaining Access to its Quell Platform, Creating Significant Player in Non-Invasive Bioelectronic Technologies - GlobeNewswire
electroCore's $4.49/Share NeuroMetrix Buyout Expands Chronic Pain Treatment Portfolio - Stock Titan
Geode Capital Management LLC Reduces Position in electroCore, Inc. (NASDAQ:ECOR) - Defense World
electroCore, Inc. Announces Integration of Truvaga Plus with Apple Health App to Enhance Wellness Tracking - Nasdaq
electroCore's Truvaga™ Now Works with the Apple Health app - The Manila Times
electroCore’s Truvaga™ Now Works with the Apple Health app - GlobeNewswire
electroCore to Announce First Quarter March 31, 2025 Financial Results on Wednesday, May 7, 2025 - GlobeNewswire
electroCore Q1 2025 Financial Results: Bioelectronic Leader Hosts Investor Webinar May 7 - Stock Titan
Press Release Distribution & PR Platform - ACCESS Newswire
The Future of Vagus Nerve Stimulation Market Growth, Innovations, and Key Trends - newstrail.com
electroCore (NASDAQ:ECOR) Shares Up 14.6% – Here’s What Happened - Defense World
Vagus Nerve Stimulators Market Set to Witness Significant - openPR.com
ElectroCore (ECOR) Reports Positive Outcomes for Traumatic Brain Injury Treatment | ECOR Stock News - GuruFocus
gammaCore Non-Invasive Vagus Nerve Stimulation (nVNS) Shown to be Effective in Treating Concussive Symptoms Associated with Mild Traumatic Brain Injuries - The Manila Times
electroCore announces new data presented on nVNS - TipRanks
electroCore, Inc. Reports Positive Data on gammaCore® for Treating Concussive Symptoms in Mild Traumatic Brain Injury at 2025 IBIA World Congress - Nasdaq
gammaCore Non-Invasive Vagus Nerve Stimulation (nVNS) Shown - GlobeNewswire
Breakthrough Study: Non-Invasive Brain Treatment Relieves 22 Concussion Symptoms in Major Clinical Trial - Stock Titan
electroCore to Participate at the Planet MicroCap Showcase - GlobeNewswire
Electrocore Inc Azioni (ECOR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.73%
0.03%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):